# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-020614
Filing Date
2024-02-27
Accepted
2024-02-27 07:01:54
Documents
105
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | apls-20231231.htm iXBRL | 10-K | 3877169
2 | EX-10.28 | apls-ex10_28.htm | EX-10.28 | 41833
3 | EX-21.1 | apls-ex21_1.htm | EX-21.1 | 22153
4 | EX-23.1 | apls-ex23_1.htm | EX-23.1 | 4262
5 | EX-31.1 | apls-ex31_1.htm | EX-31.1 | 15589
6 | EX-31.2 | apls-ex31_2.htm | EX-31.2 | 15599
7 | EX-32.1 | apls-ex32_1.htm | EX-32.1 | 8946
8 | EX-32.2 | apls-ex32_2.htm | EX-32.2 | 8708
9 | EX-97.1 | apls-ex97_1.htm | EX-97.1 | 32992
10 | PDF COURTESY COPY | apls-ex97_1.pdf | EX-97.1 | 114982
11 | GRAPHIC | img114409135_0.jpg | GRAPHIC | 13590
12 | GRAPHIC | img138179509_0.jpg | GRAPHIC | 26034
13 | GRAPHIC | img138179509_1.jpg | GRAPHIC | 78365
14 | GRAPHIC | img138179509_2.jpg | GRAPHIC | 55504
| Complete submission text file | 0000950170-24-020614.txt |  | 14997558

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | apls-20231231.xsd | EX-101.SCH | 2033482
107 | EXTRACTED XBRL INSTANCE DOCUMENT | apls-20231231_htm.xml | XML | 2387783

Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38276 | Film No.: 24681915
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)